Krystal Biotech KRYS
NASDAQ KRYS
$308.81 +2.31 (+0.75%)
At close: Nov 11, 2026 · 4:00 PM EST

Krystal Biotech (KRYS) EV to CFO (2024 - 2026)

Updated

Krystal Biotech's EV to CFO came in at 27.61 for Q3 2026, up 10.9% from 24.89 a year earlier but down 26.0% from the prior quarter.

Analysis

Krystal Biotech (KRYS) EV to CFO (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Krystal Biotech reported EV to CFO of 19.90, up 40.9% year-over-year; for FY2025, it was 31.71, unchanged from FY2024.

  • Going back by year, EV to CFO was 31.71 in FY2024.
  • The five-year range for quarterly EV to CFO is 16.86 (Q2 2025) to 73.35 (Q3 2024).
  • Year-over-year, EV to CFO increased in two of the last five quarters, with growth averaging 9.5%.
  • Business Quant data shows KRYS's EV to CFO at 37.29 (Q2 2026), 27.09 (Q1 2026) and 31.71 (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Krystal Biotech 9.08 Bn 5.67 Bn 119.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 27.61
Jun 30, 2026 37.29
Mar 31, 2026 27.09
Dec 31, 2025 31.71
Sep 30, 2025 24.89
Jun 30, 2025 16.86
Mar 31, 2025 33.17
Dec 31, 2024 31.71
Sep 30, 2024 73.35
API Access

Krystal Biotech EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=KRYS&period=max&api_key=YOUR_API_KEY